 Seth Septer
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 8 | 2022 | 40 | 2.580 |
Why?
| | Adenomatous Polyposis Coli Protein | 2 | 2018 | 20 | 1.040 |
Why?
| | Genetic Counseling | 2 | 2016 | 81 | 0.940 |
Why?
| | Hepatoblastoma | 3 | 2019 | 52 | 0.600 |
Why?
| | Dentofacial Deformities | 1 | 2018 | 1 | 0.560 |
Why?
| | Osteosclerosis | 1 | 2018 | 2 | 0.560 |
Why?
| | Osteoma | 1 | 2018 | 2 | 0.560 |
Why?
| | Mandibular Neoplasms | 1 | 2018 | 22 | 0.550 |
Why?
| | Intestinal Polyposis | 2 | 2019 | 7 | 0.540 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2016 | 237 | 0.530 |
Why?
| | Genetic Testing | 3 | 2019 | 478 | 0.530 |
Why?
| | Neoplastic Syndromes, Hereditary | 2 | 2019 | 45 | 0.520 |
Why?
| | Counselors | 1 | 2016 | 14 | 0.500 |
Why?
| | Genes, APC | 2 | 2019 | 11 | 0.500 |
Why?
| | Polyps | 1 | 2013 | 14 | 0.390 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2013 | 19 | 0.390 |
Why?
| | Esophageal Diseases | 1 | 2013 | 30 | 0.380 |
Why?
| | Esophagitis | 1 | 2013 | 66 | 0.370 |
Why?
| | Chromosome Deletion | 1 | 2013 | 124 | 0.370 |
Why?
| | Liver Neoplasms | 2 | 2016 | 780 | 0.370 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 462 | 0.340 |
Why?
| | Mutation | 4 | 2018 | 4085 | 0.330 |
Why?
| | Esophagus | 1 | 2013 | 261 | 0.330 |
Why?
| | Barrett Esophagus | 1 | 2013 | 165 | 0.320 |
Why?
| | Phosphoproteins | 1 | 2011 | 343 | 0.300 |
Why?
| | Genetic Predisposition to Disease | 2 | 2015 | 2359 | 0.300 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 427 | 0.290 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1313 | 0.270 |
Why?
| | Liver | 2 | 2018 | 1884 | 0.270 |
Why?
| | Colectomy | 2 | 2016 | 107 | 0.200 |
Why?
| | Child | 13 | 2022 | 22537 | 0.190 |
Why?
| | Radiography, Panoramic | 2 | 2021 | 14 | 0.180 |
Why?
| | Child, Preschool | 6 | 2019 | 11774 | 0.170 |
Why?
| | Infant | 6 | 2016 | 10022 | 0.150 |
Why?
| | Cromolyn Sodium | 1 | 2018 | 6 | 0.140 |
Why?
| | Colonoscopy | 3 | 2019 | 260 | 0.140 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2018 | 6 | 0.140 |
Why?
| | Colonic Polyps | 1 | 2019 | 85 | 0.140 |
Why?
| | Cell Degranulation | 1 | 2018 | 42 | 0.140 |
Why?
| | Craniopharyngioma | 1 | 2019 | 77 | 0.140 |
Why?
| | Jaw | 1 | 2018 | 27 | 0.140 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 190 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2017 | 2494 | 0.130 |
Why?
| | beta Catenin | 1 | 2019 | 252 | 0.130 |
Why?
| | Mast Cells | 1 | 2018 | 146 | 0.120 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 71 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2017 | 186 | 0.120 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 7 | 0.120 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 26 | 0.120 |
Why?
| | Chemoprevention | 1 | 2016 | 90 | 0.120 |
Why?
| | Adolescent | 7 | 2019 | 22281 | 0.120 |
Why?
| | Capsule Endoscopy | 1 | 2015 | 25 | 0.110 |
Why?
| | Prevalence | 2 | 2021 | 2815 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 781 | 0.110 |
Why?
| | Genetic Diseases, Inborn | 1 | 2014 | 44 | 0.110 |
Why?
| | Lymphoproliferative Disorders | 1 | 2014 | 57 | 0.110 |
Why?
| | Humans | 17 | 2022 | 144261 | 0.100 |
Why?
| | Male | 10 | 2019 | 72035 | 0.100 |
Why?
| | Failure to Thrive | 1 | 2013 | 28 | 0.100 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2013 | 10 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 207 | 0.100 |
Why?
| | Stomach | 1 | 2013 | 109 | 0.090 |
Why?
| | Pediatrics | 3 | 2019 | 1112 | 0.090 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 78 | 0.090 |
Why?
| | Vomiting | 1 | 2013 | 130 | 0.090 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 343 | 0.090 |
Why?
| | Self Report | 1 | 2016 | 863 | 0.090 |
Why?
| | Colorectal Neoplasms | 2 | 2019 | 844 | 0.090 |
Why?
| | Gastritis | 1 | 2013 | 115 | 0.090 |
Why?
| | Ion Transport | 1 | 2011 | 63 | 0.090 |
Why?
| | Abdominal Pain | 1 | 2013 | 146 | 0.090 |
Why?
| | Female | 10 | 2019 | 77976 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 164 | 0.090 |
Why?
| | Phenotype | 3 | 2019 | 3157 | 0.090 |
Why?
| | Deglutition Disorders | 1 | 2013 | 147 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2017 | 1125 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2016 | 11643 | 0.080 |
Why?
| | Tretinoin | 1 | 2011 | 124 | 0.080 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 628 | 0.080 |
Why?
| | Organ Size | 1 | 2011 | 462 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 269 | 0.080 |
Why?
| | Bile Acids and Salts | 1 | 2011 | 164 | 0.080 |
Why?
| | Collagen | 1 | 2013 | 455 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 463 | 0.080 |
Why?
| | Mass Screening | 1 | 2019 | 1332 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3592 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1495 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2019 | 17009 | 0.080 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2011 | 370 | 0.070 |
Why?
| | Optic Neuritis | 1 | 2008 | 44 | 0.070 |
Why?
| | Bronchiolitis | 1 | 2008 | 87 | 0.060 |
Why?
| | Pneumonia, Bacterial | 1 | 2008 | 113 | 0.060 |
Why?
| | Feeding and Eating Disorders | 1 | 2008 | 162 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5988 | 0.060 |
Why?
| | Biopsy | 2 | 2022 | 1075 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1782 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2011 | 2048 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2430 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2525 | 0.050 |
Why?
| | Adult | 4 | 2021 | 40262 | 0.040 |
Why?
| | Clinical Competence | 1 | 2008 | 1241 | 0.040 |
Why?
| | Young Adult | 2 | 2013 | 13990 | 0.040 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2019 | 70 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 136 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 172 | 0.030 |
Why?
| | Point Mutation | 1 | 2019 | 243 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 732 | 0.030 |
Why?
| | Connective Tissue Growth Factor | 1 | 2017 | 27 | 0.030 |
Why?
| | Animals | 3 | 2018 | 38030 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4556 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 488 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 3313 | 0.030 |
Why?
| | Adenoma | 1 | 2019 | 218 | 0.030 |
Why?
| | Gastroenterology | 1 | 2019 | 188 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 476 | 0.030 |
Why?
| | Electronic Mail | 1 | 2015 | 61 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 729 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2926 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 52 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 68 | 0.030 |
Why?
| | Canada | 1 | 2015 | 428 | 0.030 |
Why?
| | Mice | 1 | 2011 | 18329 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 538 | 0.030 |
Why?
| | Dyspepsia | 1 | 2013 | 10 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2013 | 52 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1137 | 0.020 |
Why?
| | Needs Assessment | 1 | 2015 | 401 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1487 | 0.020 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 62 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 50 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2840 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 388 | 0.020 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2011 | 62 | 0.020 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 355 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 205 | 0.020 |
Why?
| | Cholangiocarcinoma | 1 | 2011 | 105 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3119 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1732 | 0.020 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 127 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1044 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4146 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5813 | 0.020 |
Why?
| | Cell Communication | 1 | 2011 | 324 | 0.020 |
Why?
| | Moraxellaceae Infections | 1 | 2008 | 3 | 0.020 |
Why?
| | Cell Survival | 1 | 2011 | 1098 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 1057 | 0.020 |
Why?
| | Sampling Studies | 1 | 2008 | 99 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2111 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1812 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 748 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 478 | 0.010 |
Why?
| | Internship and Residency | 1 | 2015 | 1255 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3539 | 0.010 |
Why?
| | Transcription Factors | 1 | 2011 | 1739 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 5221 | 0.010 |
Why?
| | United States | 1 | 2015 | 15876 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1906 | 0.010 |
Why?
|
|
Septer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|